Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Alzheimer's disease
Recent news which mentions Alzheimer's disease
< Previous
1
2
3
Next >
FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023
Tags
Health & Science
Policy
US Top News and Analysis
From
CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
May 03, 2023
Tags
Politics
Health & Science
US: News
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Eli Lilly and Co
US: News
Health & Science
From
CNBC.com News
March 2023 Miscellany
March 27, 2023
Tags
Breast Cancer
Cancer
lung cancer
From
Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
January 17, 2023
Tags
Anavex Life Sciences (AVXL)
metformin
Eisai (ESALY)
From
Stock Gumshoe
Relevant Updates – December 2022
December 27, 2022
Tags
Biogen Idec (BIIB)
Doc Gumshoe
Merck (MRK)
From
Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Tickers
MOR
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
MOR
From
Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
November 13, 2022
Tags
Diets and dieting
Dementia
Local food
From
CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
November 07, 2022
Tickers
SPRC
Tags
Markets
General
News
From
Benzinga
Odd & Ends – October 2022
October 27, 2022
Tags
ALS / Lou Gehrig's Disease
Eisai (ESALY)
Amylx Pharmaceuticals (AMLX)
From
Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Tickers
ABOS
ACIU
ALZN
ANVS
Tags
BIIB
Alzheimer's disease
ANVS
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
Analyst Color
Marc Goodman
News
From
Benzinga
Following Up on Your Suggestions – September 2022
September 26, 2022
Tickers
DIET
Tags
vitamins
Roche (RHHBF RHHBY)
NervGen Pharma (NGEN/V NGENF)
From
Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
August 10, 2022
Tickers
DGX
Tags
Dr Pat Alagia
Health & Healthcare
Events, Media & Communications
From
3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
August 04, 2022
Tickers
CGTX
Tags
Exclusives
Market News
CGTX
From
Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
July 19, 2022
Tags
Doc Gumshoe
ProMIS Neurosciences (PMN/TO ARFXF)
INmune Bio (INMB)
From
Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
July 08, 2022
Tickers
ABBV
ALEC
Tags
News
Briefs
General
From
Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
June 13, 2022
Tags
Alzheimer's Disease
Guest Articles
Cassava Sciences (SAVA)
From
Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
May 23, 2022
Tickers
BIIB
Tags
Market News
Benzinga
Biotech
From
Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
May 10, 2022
Tags
Doc Gumshoe
Alzheimer's Disease
Eisai (ESALY)
From
Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
Briefs
News
From
Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
April 19, 2022
Tickers
SAVA
Tags
Movers
News
why it's moving
From
Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
April 13, 2022
Tickers
LGVN
Tags
Market News
Exclusives
Phase 2 Trial
From
Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
April 08, 2022
Tickers
BIIB
Tags
News
Government
General
From
Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Tickers
LGVN
Tags
Exclusives
News
General
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
General
News
From
Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
March 16, 2022
Tickers
BIIB
Tags
Market News
Benzinga
News
From
Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
March 16, 2022
Tickers
PRTA
Tags
News
Briefs
General
From
Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
March 15, 2022
Tickers
GANX
Tags
General
Briefs
News
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Health Care
Alzheimer's disease
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.